TSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/28/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTSE
Market Capitalization4,689.84 mln
Float54.99 mln
Earnings Date08/07/2025
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-2.7
Likely reliable
Relative Strength
99
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
-23.46
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
MedRx Co. Ltd is a Japan-based drug development company focused on delivering medicines through the skin rather than by injection or tablet. Founded in 2002 and based in Higashikagawa, the company uses proprietary skin absorption technologies to create treatments for conditions such as neuropathic pain, spastic paralysis, schizophrenia, and chronic pain. Its most advanced product has already received approval from US regulators, while several others are currently moving through clinical trials. MedRx also develops needle patch systems designed to deliver vaccines and other active ingredients directly through the skin.
